Literature DB >> 21945457

Early, severe and bilateral loss of LTP and LTD-like plasticity in motor cortex (M1) in de novo Parkinson's disease.

Asha Kishore1, Thomas Joseph, Balu Velayudhan, Traian Popa, Sabine Meunier.   

Abstract

OBJECTIVE: To test the plasticity of bilateral motor cortices (M1) in treatment-naïve (de novo) Parkinson's disease (PD) patients and its response to single dose of L-DOPA.
METHODS: Twenty-one de novo PD patients with only unilateral motor symptoms were recruited to eliminate the effects of advanced disease and chronic treatment and were tested with intermittent (n=10) and continuous theta burst stimulation (iTBS and cTBS) (n=11) protocols to induce LTP and LTD-like plasticity on both M1 cortices. They were compared with two groups of 10 each, age-matched, healthy volunteers (HV). Severity of motor signs and effectiveness of TBS were measured bilaterally in the untreated state and after a uniform dose of L-DOPA in all patients.
RESULTS: iTBS and cTBS induced significant LTP and LTD- like plasticity in M1 of HV. In de novo patients, there was no plasticity in both M1. Acute L-DOPA challenge did not improve plasticity in either M1 cortices, though motor signs of PD improved. There was no correlation of motor signs with M1 plasticity.
CONCLUSION: The early, severe and bilateral loss of plasticity in M1 in de novo PD patients is a primary disease-related cortical dysfunction. The contrasting L-DOPA response of motor signs and M1 plasticity could arise from differences in neural circuits mediating them or differing effects of acute dopamine replacement on circuits recruited by specific plasticity-induction techniques, particularly in treatment naïve PD. SIGNIFICANCE: M1 plasticity defect occurs early in PD and might affect motor learning. Acute vs. chronic dopamine replacement could have different effects on plasticity in PD or in the networks recruited by a specific plasticity induction technique.
Copyright © 2011 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945457     DOI: 10.1016/j.clinph.2011.06.034

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  36 in total

Review 1.  Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?

Authors:  Paolo Calabresi; Veronica Ghiglieri; Petra Mazzocchetti; Ilenia Corbelli; Barbara Picconi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

Review 2.  Motor learning in animal models of Parkinson's disease: Aberrant synaptic plasticity in the motor cortex.

Authors:  Tonghui Xu; Shaofang Wang; Rupa R Lalchandani; Jun B Ding
Journal:  Mov Disord       Date:  2017-03-25       Impact factor: 10.338

3.  TMS enhances retention of a motor skill in Parkinson's disease.

Authors:  Clara Moisello; Daniella Blanco; Cecilia Fontanesi; Jing Lin; Milton Biagioni; Pawan Kumar; Miroslaw Brys; Andrea Loggini; Lucio Marinelli; Giovanni Abbruzzese; Angelo Quartarone; Giulio Tononi; Alessandro Di Rocco; Maria Felice Ghilardi
Journal:  Brain Stimul       Date:  2014-11-15       Impact factor: 8.955

Review 4.  The many facets of motor learning and their relevance for Parkinson's disease.

Authors:  Lucio Marinelli; Angelo Quartarone; Mark Hallett; Giuseppe Frazzitta; Maria Felice Ghilardi
Journal:  Clin Neurophysiol       Date:  2017-04-09       Impact factor: 3.708

Review 5.  The role of neuroplasticity in dopaminergic therapy for Parkinson disease.

Authors:  Xiaoxi Zhuang; Pietro Mazzoni; Un Jung Kang
Journal:  Nat Rev Neurol       Date:  2013-04-16       Impact factor: 42.937

Review 6.  The pharmacology of neuroplasticity induced by non-invasive brain stimulation: building models for the clinical use of CNS active drugs.

Authors:  Michael A Nitsche; Florian Müller-Dahlhaus; Walter Paulus; Ulf Ziemann
Journal:  J Physiol       Date:  2012-08-06       Impact factor: 5.182

Review 7.  Evolving concepts on bradykinesia.

Authors:  Matteo Bologna; Giulia Paparella; Alfonso Fasano; Mark Hallett; Alfredo Berardelli
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

8.  Cerebellar and Motor Cortical Transcranial Stimulation Decrease Levodopa-Induced Dyskinesias in Parkinson's Disease.

Authors:  Roberta Ferrucci; Francesca Cortese; Marta Bianchi; Dario Pittera; Rosanna Turrone; Tommaso Bocci; Barbara Borroni; Maurizio Vergari; Filippo Cogiamanian; Gianluca Ardolino; Alessio Di Fonzo; Alessandro Padovani; Alberto Priori
Journal:  Cerebellum       Date:  2016-02       Impact factor: 3.847

9.  Learning Similar Actions by Reinforcement or Sensory-Prediction Errors Rely on Distinct Physiological Mechanisms.

Authors:  Shintaro Uehara; Firas Mawase; Pablo Celnik
Journal:  Cereb Cortex       Date:  2018-10-01       Impact factor: 5.357

10.  Paradoxical facilitation after depotentiation protocol can precede dyskinesia onset in early Parkinson's disease.

Authors:  Angel Lago-Rodriguez; Viviana Ponzo; Ned Jenkinson; Sonia Benitez-Rivero; Miguel Fernandez Del-Olmo; Michele Hu; Giacomo Koch; Binith Cheeran
Journal:  Exp Brain Res       Date:  2016-08-26       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.